Impacts of Oral Irrigation in Orthodontic Patients
Clinical and Biochemical Evaluation Oral Irrigator Effectiveness in Patients Under Orthodontic Treatment
1 other identifier
interventional
30
1 country
1
Brief Summary
The present study aimed to investigate clinically the cleaning effectiveness of different treatment modalities, that is, oral irrigator or interdental brush usage addition to routine brushing and examine interleukin (IL)-1β, IL-10, matrix metalloproteinase (MMP)-1, MMP-8 levels in gingival crevicular fluid of orthodontic patients. The null hypothesis was that oral irrigators would be effective compared to interdental brush in the oral care of individuals who are orthodontic patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 27, 2018
CompletedFirst Submitted
Initial submission to the registry
September 28, 2022
CompletedFirst Posted
Study publicly available on registry
October 3, 2022
CompletedOctober 3, 2022
September 1, 2022
5 months
September 28, 2022
September 28, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
GCF (gingival crevicular fluid) level of IL-1β as a marker of gingival inflammation
Elevated levels of IL-1β in GCF have been associated with the destructive changes that occur in the inflamed human gingiva, is a proinflammatory cytokine.
through study completion, an average of 1 year
GCF (gingival crevicular fluid) level of IL-10 as a marker of gingival inflammation
IL-10 plays an important role as a stop signal in suppressing the immune and inflammatory response by being released from periodontal tissues, thus trying to limit the spread and severity of the disease. It is an anti-inflammatory cytokine. It is reported that the level of GCF IL-10 is increased in inflamed areas.
through study completion, an average of 1 year
GCF (gingival crevicular fluid) level of MMP-1 as a marker of gingival inflammation
One of the MMPs, MMP-1, is generally expressed by fibroblasts, endothelial cells, keratinocytes, monocytes/macrophages, chondrocytes, and osteoblasts, and is a key regulator in connective tissue remodeling. In addition to gingivitis, there is a significant increase in MMP-1 levels in the GCF during the active periods of periodontitis.
through study completion, an average of 1 year
GCF (gingival crevicular fluid) level of MMP-8 as a marker of gingival inflammation
High concentration of MMP-8 is associated with tissue destruction and severity of periodontal disease. It is known to be secreted from inflammatory cells such as neutrophils and macrophages.
through study completion, an average of 1 year
Study Arms (2)
Oral irrigator group
EXPERIMENTALFifteen patients using toothbrush and oral irrigator (Aquapick, AQ-300, Aquapick Co, Ltd, Korea). All patients were told to use Modified Bass method of tooth brushing technique. PI, GI, PPD and CAL values were measured with William's probe (Hu-Fried, Chicago, IL, A.B.D) around the teeth. All clinical parameters were evaluated on each of the six regions of the teeth (mesio-buccal, mid-buccal, disto-buccal, mesio-lingual, mid-lingual, disto-lingual). GCF (gingival crevicular fluid) samples was collected one day after the clinical examination from buccal aspects of the mesial and distal surfaces at the interproximal sites for the evaluation of interleukin (IL)-1β, IL-10, matrix metalloproteinase (MMP)-1, MMP-8 mediators. Following the initial clinical records, all patients were performed full mouth instrumentation and described oral hygiene procedure according to their groups.
Interdental brush group
EXPERIMENTALFifteen patients using toothbrush and interdental brush. All patients were told to use Modified Bass method of tooth brushing technique. PI, GI, PPD and CAL values were measured with William's probe (Hu-Fried, Chicago, IL, A.B.D) around the teeth. All clinical parameters were evaluated on each of the six regions of the teeth (mesio-buccal, mid-buccal, disto-buccal, mesio-lingual, mid-lingual, disto-lingual). GCF (gingival crevicular fluid) samples was collected one day after the clinical examination from buccal aspects of the mesial and distal surfaces at the interproximal sites for the evaluation of interleukin (IL)-1β, IL-10, matrix metalloproteinase (MMP)-1, MMP-8 mediators. Following the initial clinical records, all patients were performed full mouth instrumentation and described oral hygiene procedure according to their groups.
Interventions
Prior to GCF (gingival crevicular fluid) sampling, supragingival plaque was removed by sterile curets and, after air drying, the surfaces were isolated by cotton rolls. Filter paper strips (periopaper, proflow Inc., Amityville, NewYork, USA) were placed in sulcus for 30s. Care was taken not to avoid mechanical trauma and strips contaminated with blood or saliva were discarded. The absorbed GCF volume was estimated by a calibrated instrument (periotron 8000, proflow Inc., Amityville, NY, USA). Then, the strips were sealed into sterile tubes before freezing at -80 0C. The readings were converted to an actual volume (μl) by reference to the standard curve.
Eligibility Criteria
You may qualify if:
- Being over 12 years old.
- Having at least 20 permanent teeth with bands or brackets.
- Finished phase I periodontal treatment.
- Bleeding below 10% during probing.
- No pocket depth of more than 5 mm.
- Not receiving any treatment other than orthodontic treatment during the study.
- Absence of removable or fixed prosthetic restorations.
- Absence of any systemic disease (hepatic, renal, hematologic, cardiovascular).
- Agreeing not to use any non-study mouthwash throughout the study.
You may not qualify if:
- Performing poor cooperation.
- Having diseases associated with bacteriemia.
- Used antibiotics and anti-inflammatory drugs for any purpose for a long time.
- Having diabetes.
- Smoking habits.
- Having a physical or mental problem that affects manual dexterity.
- Using medication that could affect gingival health (such as dilantin, calcium channel blocker, cyclosporine, and anticoagulant).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ondokuz Mayıs University, Faculty of Dentistry, Department of Periodontology
Samsun, 55270, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Burcu OZKAN CETINKAYA, Prof
Ondokuzmayis University, Faculty of Dentistry, Department of Periodontology, Samsun, Turkey.
- PRINCIPAL INVESTIGATOR
Esma SAHIN, Dr
Erzurum Public Oral Health Center, Erzurum, Turkey.
- STUDY CHAIR
Bahattin AVCI, Prof
Ondokuzmayis University, Faculty of Medicine Department of Biochemistry, Samsun, Turkey.
- STUDY CHAIR
Selma ELEKDAG TURK, Prof
Ondokuzmayis University, Faculty of Dentistry, Department of Orthodontics, Samsun, Turkey.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor in Periodontology
Study Record Dates
First Submitted
September 28, 2022
First Posted
October 3, 2022
Study Start
March 1, 2018
Primary Completion
August 1, 2018
Study Completion
December 27, 2018
Last Updated
October 3, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share